Here is the latest stock price and chart of AJANTA PHARMA. For more details, see the AJANTA PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
DISCOVER: How to Potentially Multiply Your Returns by Upto 5x...
Live BSE Quotes | Mar 5, 2021 (Close) | ||
---|---|---|---|
Price (Rs)1,751.45 | Open (Rs) 1,735.00 | High (Rs) 1,761.90 | Low (Rs) 1,712.95 |
% Change0.61 | Volume 4,013 | Value (Rs) 6,987,362 | 52-Week H/L 1,879.45 / 961.65 |
Live NSE Quotes | Mar 5, 2021 (Close) | ||
---|---|---|---|
Price (Rs)1,752.70 | Open (Rs) 1,749.00 | High (Rs) 1,761.00 | Low (Rs) 1,711.90 |
% Change0.59 | Volume 88,631 | Value (Rs) 154,016,026 | 52-Week H/L 1,878.00 / 961.00 |
Change | |||||
---|---|---|---|---|---|
1 Day 0.61% | 1 Month -3.43% | 3 Months 4.35% | 1 Year 18.75% | 5 Years (CAGR)* 4.26% | 10 Years (CAGR)* 52.25% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 70.92 | P/E Ratio (x) 24.70 | Market Cap (Rs m) 154,040.03 | P/BV (x) 6.86 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
AJANTA PHARMA last traded price was up 0.6% to Rs 1,751.5 on the BSE. On the NSE, AJANTA PHARMA last traded price was up 0.6% to Rs 1,752.7. The total volume of shares traded was 0.1 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 1.5%. And the benchmark S&P BSE SENSEX was at 50,405.3 (down 0.9%).
Over the last 30 days, the AJANTA PHARMA share price is down 3.3%. And over the last one year, AJANTA PHARMA share price is up 15.9%.
What else is happening in the markets today? Dig in...
The week belonged to the bulls after bears ended the party in February. March started with gains for the bulls but historically, March has been a bears' month.
For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.
For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.
Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.
More Views on NewsLast time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
In this video, I'll show you how to get started on the path to daily trading profits.
An Indian company founded three decades ago in a garage caught my attention...
In this video, I'll show you how to allocate your capital as a day trader.
More